Three factors to make a next-gen eCOA platform work
Melissa Mooney, Director, eCOA Solutions Engineering, IQVIA, emphasises that as timelines tighten, regulatory scrutiny…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
IQVIA
Glenmark launches Lacosamide Oral Solution, bioequivalent to Vimpat
Lacosamide Oral Solution, 10 mg/mL, enters the U.S. market with an annual market size of $57 million
Glenmark ranks No.1 in dermatologist prescriptions for protective emollients and derma therapy:…
Glenmark Pharmaceuticals has been ranked number 1 in dermatologists’ prescriptions in the protective emollients category and for…
IQVIA and Dr Reddy’s partner for CRM solution
Dr Reddy’s will rollout IQVIA’s OCE application to its entire field force and marketing users in India to drive more meaningful…
GSK, IQVIA launch Vaccine Track, a data trend platform to improve adult vaccination in US
Vaccine Track data insights revealed sustained decline of recommended adult immunisations, excluding flu vaccinations, across the…
Lupin launches Droxidopa capsules in US
Droxidopa Capsules, 100 mg, 200 mg and 300 mg is a generic equivalent of Northera capsules, 100 mg, 200 mg and 300 mg, of Lundbeck…
Lupin launches authorised generic version of Duexis in US
Ibuprofen and Famotidine tablets, 800 mg/26.6 mg, are indicated for the relief of signs and symptoms of rheumatoid arthritis and…
Alembic Pharmaceuticals’ joint venture Aleor Dermaceuticals receives US FDA’s final…
Metronidazole gel USP, 1% has an estimated market size of $29 million for twelve months ending June 2021, according to IQVIA
IQVIA announces JAPAC expansion of IQVIA Biotech
Since its launch, IQVIA Biotech has initiated hundreds of new trials for biotech companies, including COVID-19 trials
Virtual clinical trials would have a tremendous advantage in expanding the reach of clinical trials
Suneela Thatte, VP and Head - R&D Solutions India, IQVIA speaks on the challenges faced by CROs due to the pandemic, the…